- This event has passed.
Medical Researcher Seminar: Coming of age of theranostics
May 18 @ 12:00 pm - 1:00 pm
Prof Philip Hogg
Head, ACRF Centenary Cancer Research Centre
About the talk: Cancer is responsible for 1 in 6 deaths globally and the economic cost is trillions of dollars annually. Recent successes of theranostics for treatment of neuroendocrine and prostate cancer has ignited interest in this treatment modality for refractory cancers. A theranostic employs a tumour marker to deliver a therapeutic isotope to the tumour. We are developing a theranostic that has an inbuilt self-amplifying anti-tumour effect and should be effective against all types of tumours.
About the speaker: Philip Hogg holds the Chair in Translational Cancer Research at University of Sydney, is Deputy Director of the Centenary Institute and Sydney Catalyst and Heads the ACRF Centenary Cancer Research Centre. He graduated with a PhD in biochemistry from the University of Queensland. His post-doctoral training was in the USA and Sweden followed by visiting fellowships at Children’s Hospital, Harvard University and the Dunn School of Pathology, University of Oxford.
Read more about Prof Philip Hogg’s work here.
Register to attend in the link below.